Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHP buyout of Genetics Institute marks departure from Roche/Genentech model for biotech agreement.

Executive Summary

AHP BUYOUT OF GENETICS INSTITUTE IS DEPARTURE FROM ROCHE/GENENTECH model of brandname/biotech partnerships followed by American Home Products when it acquired a majority stake in Genetics Institute in 1991. That agreement was patterned on Roche's partial acquisition of Genentech. Both deals gave the parent company the option to buy out the rest of the biotech firm at set prices over five years.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel